Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design-Reference-Cited by-同舟云学术

Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design

Published:2023-08 Issue:35 Volume:41 Page:5134-5140
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Zimmerman Richard K.,Patricia Nowalk Mary,Dauer Klancie,Clarke Lloyd,Raviotta Jonathan M.,Balasubramani G.K.

Funder

Sanofi

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference19 articles.

1. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates;Ohmit;Clin Infect Dis,2014

2. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type;McLean;J Infect Dis,2015

3. Influenza vaccine effectiveness against 2009 pandemic influenza A (H1N1) virus differed by vaccine type during 2013–2014 in the United States;Gaglani;J Infect Dis,2016

4. 2014–2015 influenza vaccine effectiveness in the United States by vaccine type;Zimmerman;Clin Infect Dis,2016

5. Influenza vaccine effectiveness in the United States — 2015/16 season;Jackson;N Engl J Med,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age;Vaccine;2024-10

2. Intranasal administration of octavalent next-generation influenza vaccine elicits protective immune responses against seasonal and pre-pandemic viruses;Journal of Virology;2024-08-22

3. Effectiveness of the influenza vaccine for preventing laboratory-confirmed influenza infections in outpatient immunocompromised adults, 2017–2018;Human Vaccines & Immunotherapeutics;2024-06-19

4. Vaccines for the Elderly and Vaccination Programs in Europe and the United States;Vaccines;2024-05-22

5. Differential Induction of Interferon-Stimulated Genes by Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Children During the 2018–2019 Season;The Journal of Infectious Diseases;2023-09-04